Document is current
Any future updates will be listed below
-
Authors
Liu, An-Bang
Lin, Yan-Xia
Meng, Ting-Ting
Tian, Peng
Chen, Jian-Lin
Zhang, Xin-He
Xu, Wei-Hong
Zhang, Yu
Zhang, Dan
Zheng, Yan
Su, Guo-Hai
-
Funding
Funding for this research was provided by:
Internationally Standardized Tumor Immunotherapy and Key Technology Platform Construction for Clinical Trials of Drug-Induced Heart Injury (2020ZX09201025, 2020ZX09201025)
Natural Science Foundation of Shandong Province (ZR2021MH019, ZR2021MH019)
- License Information
-
More Information
Article History
Received: 11 May 2024
Accepted: 2 August 2024
First Online: 15 October 2024
Declarations
:
: This study was conducted in accordance with the principles of the Declaration of Helsinki. The investigation was approved by the NCHS research ethics review board. The NHANES database used in this study did not contain identifiable nor protected health information, and was publicly available for download. All participants have provided written informed consent to the NHANES.
: Not applicable.
: The authors declare no competing interests.
: No disclosures were reported.
